Evidence map›Paper›PMID 40663121›Full record

ArticleSouthern medical journal2025

Online Interest in Colorectal Cancer Screening in Florida.

Raghuram V Reddy, Karla C Santoyo, Varun Hariharan, Jay Desai, Amalia Landa-Galindez

Abstract read
In one paragraph

Article in Southern medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Raghuram V ReddyFrom the Herbert Wertheim College of Medicine, Florida International University, Miami.ORCID https://orcid.org/0000-0002-9921-5735
Karla C SantoyoFrom the Herbert Wertheim College of Medicine, Florida International University, Miami.
Varun HariharanFrom the Herbert Wertheim College of Medicine, Florida International University, Miami.
Jay Desai
Amalia Landa-GalindezDepartment of Translational Medicine, Division of Internal Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveColorectal cancer (CRC) is the third most common cancer worldwide and the second most common cause of cancer death for men and women combined. It is estimated that in 2024, 53,010 people will have died from CRC. The objective of this study was to analyze online interest in CRC screening in Florida.

methodsGoogle Trends was queried for "colorectal cancer screening," "fecal occult blood test," and "colonoscopy" from 2004 to the present. The relative search volume (RSV) ranged from 0 to 100, with 0 meaning no interest and 100 signifying maximum popularity.

resultsGoogle Trends analysis revealed variations in interest for CRC screening, fecal occult blood test as a screen, and colonoscopy across Florida metropolitan areas. Gainesville consistently ranked high for all three terms. Interest peaked for screening in 2009 and 2022, for fecal occult blood test in 2024, and for colonoscopy in 2007. Related search terms focused on screening guidelines, procedures, and preparation.

conclusionsGoogle Trends can provide a useful tool for evaluating interest in Florida for CRC screening, which is important because there are screening disparities across Florida counties compared with national and state averages. By identifying areas with lower search interest, healthcare providers and public health organizations can target community interventions based on the specific barriers faced by residents in each metropolis.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerInternetColonoscopyFemaleFloridaHumansMaleOccult Blood

Identifiers

PMID40663121
PMCPMC12244983

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.